Trials / Completed
CompletedNCT06259656
Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.
Antibody Response to Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Vachira Phuket Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV.
Detailed description
The goal of this study is to study the correlation of maternal and cord blood level of Anti SAR-CoV. Sample size is 40 Thai patients at labor room Vachira Phuket Hospital in October - November 2023, who have at least one COVID-19 vaccination before or when pregnant. The Secondary outcome is to study time effect after COVID-19 vaccination and effect of vaccine type on Antibody level.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) | Maternal blood and cord blood were collected to test for COVID-19 Spike Protein IgG Quantitative Antibody (CMIA) |
Timeline
- Start date
- 2023-10-25
- Primary completion
- 2023-11-25
- Completion
- 2023-11-25
- First posted
- 2024-02-14
- Last updated
- 2024-07-03
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT06259656. Inclusion in this directory is not an endorsement.